Health
AHA: New Medication, Finerenone, Helps Heart Health in People With Chronic Kidney Disease, Type 2 Diabetes – Cath Lab Digest
DALLAS, Nov. 17, 2020 — The investigational medication finerenone reduced the risk of heart attack, stroke, heart failure and other negative cardiovascular events…
DALLAS, Nov. 17, 2020 — The investigational medication finerenone reduced the risk of heart attack, stroke, heart failure and other negative cardiovascular events in patients with chronic kidney disease and Type 2 diabetes, according to late-breaking research presented at the American Heart Association’s Scientific Sessions 2020. The virtual meeting is Friday, November 13-Tuesday, November 17, 2020, and is a premier global exchange of the latest scientific advancements, research and evidence-based…
-
Business24 hours agoWhy did ASX 200 energy shares rip up the charts on Friday?
-
General21 hours agoNRL updates: Gold Coast Titans upset Manly Warringah Sea Eagles 28-8, Haumole Olakau’atu suffers shoulder injury
-
Noosa News23 hours agoQueensland tobacco store torched after masked men smash in with hammer as police probe links to mall heist
-
General22 hours agoSoldiers and scientists the faces of the dead in aftermath of Israel’s strike on Iran